Entrada Therapeutics

A round of applause for this group of recently promoted Entradans! 👏🏽👏🏾👏🏿👏🏻 Each one of you exemplify the core values of Entrada – endless curiosity, tenacity and creativity. Together, our incredible team drives scientific innovation with the shared goal of making a meaningful difference for patients and their families. We’re looking forward to seeing your next achievements.    Alex Bonanno, Amanda Dombroski, Eric T. Williams, Ph.D., Kimberli Kamer, Molly O'Connor, CPA, Mufan Xu, Nelsa Estrella, Ph.D., Nick Long, Patrick Dougherty, Pauline Tan, PhD, Sara B., Silvia Pasini, PhD, Varick Ho, Wenlong (Bill) Lian, Zekun Liu   Interested in joining our team? Apply here: https://lnkd.in/eXjmC27B   #EntradaHere #CareerGrowth #TopPlaceToWork

Last week I had the privilege of talking with Yuva G., Entrada’s remarkable Finance and Accounting Intern. Yuva is attending the University of Pennsylvania as a cognitive science, computation and cognition major and also, as he says, “living life to the fullest despite Duchenne muscular dystrophy”. It is not every day that we get an opportunity to bring on an intern who lives with the disease that our teams are so persistent in finding treatments for, especially one as talented as Yuva.    Yuva shared so many amazing insights on life and learning. We also discussed the ways we can continue building upon patient-focused drug development, advancing accessibility and inclusivity for all and taking a moment to focus on what really matters to each of us.    Thank you to Yuva G., from the entire Entrada team!

Next week, Entrada will be attending the Skeletal Muscle Stem Cells in Development Regenerations & Adaptations conference on July 14-19, 2024, in Estérel, Québec. Nelsa Estrella, Ph.D., Associate Director, Neuromuscular Therapeutics, will be presenting a poster titled, “Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD Cell Model”. We hope to see you there! Learn more about our scientific presentations and manuscripts: https://lnkd.in/ed8345DB #EntradaHere #DMD

Supporting our employees' career development is a core focus at Entrada. Sometimes, this means encouraging and celebrating colleagues whose next step is moving beyond Entrada. We are proud of our newest #EntradaAlumni as they head back to school to start advanced degree programs at Tufts University, Northeastern University School of Law and University College Cork. Congratulations to Alison Burman, Emily Kealey and Kayla Gunning. We will always be rooting for you!   Learn more about what it's like to work with us: https://lnkd.in/eMt4CsU   #EntradaHere #BackToSchool #Biotech

#ICYMI: The Entrada team attended the 6th Annual RNA Therapeutics Conference. Xiulong (Mark) Shen, Senior Scientist II, Discovery Research, presented a poster titled, “Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle”. The event was a great opportunity to connect with colleagues and discuss the latest innovations in RNA therapeutics.   #EntradaHere #Biotech

Final call for applications! This Friday is the last day to apply for the Entrada Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program. Entrada DREAMS is awarding three grants of $25,000 (USD) each to U.S. based non-profit organizations with project proposals that embrace diversity, inclusivity, accessibility and the creation or expansion of vital services to achieve greater equality within the Duchenne community.   The deadline to submit an application is Friday, July 12, 2024, at 11:45pm ET. To learn more and apply visit: www.entradatx.com/dreams.   #EntradaDREAMS #EntradaHere #DMD

From all of us at Entrada, have a safe, happy and relaxing 4th of July! #EntradaHere #IndependenceDay

We are delighted to watch our team grow. Please join us in welcoming our newest Entradans: · Meghan MacNally (Director, Clinical Operations) · Sean O'Donnell (Senior Research Associate, Discovery Chemistry) · Rose Lewis (Manager, Total Rewards & People Operations) · miriam moncayo (Executive Assistant, Corporate) · Divya Reddy, MD (Medical Director, Clinical Development) · Pressley Smith (Research Associate II, Translational) Interested in joining our team of dedicated Entradans? Explore our careers page and apply: https://lnkd.in/eXjmC27B #TopPlaceToWork #EntradaHere #Hiring

Last week, the Entrada team attended Parent Project Muscular Dystrophy’s 2024 Annual Conference. Sweta Girgenrath, PhD, Vice President, Head of Cardiovascular and Neuromuscular Therapeutic Areas, presented preliminary data from our Phase 1 ENTR-601-44-101 trial for Duchenne muscular dystrophy. The team was also joined by Natarajan Sethuraman, PhD, Entrada’s Chief Scientific Officer.    We enjoyed speaking with patient advocacy organizations, families, key opinion leaders and industry professionals. We're ready to apply what we've learned. See you all next year!    #EntradaHere #Duchenne #DMD

Pride month has come to an end, but #PrideNeverEnds at Entrada. We stand as allies 365 days of the year, advocating for equal rights and creating a work environment where everyone can belong are a part of our core values.    Here are a few ways we live our commitment: · As a company we have publicly stated our commitment to diversity and apply DE&I principles across our work, every day  · Through our partnerships with patient advocacy organizations, we are actively working to identify and address discrimination and disparity in health care within both the Duchenne and rare disease communities · Our Pride committee sponsored a fireside chat and performance with prominent LGBTQ+ activist and drag performer, Candace Persuasian and Karla MacDonald, our Chief Corporate Affairs Officer · We are an active corporate member of OUTbio, supporting the 2nd OUTbio June Event  · We’ve partnered with Human Rights Campaign to support their annual gala and leverage their best practices in our benefits strategy · Our healthcare benefits include gender affirming care · We offer the opportunity to include our pronouns in our email signatures · Our Corporate and R&D site has a non-gendered restroom · We encourage and equip teammates to have courageous conversations · We use our Cultural Intelligence or CQ Chat on Microsoft Teams so that everyone can share and celebrate moments that are important to them   Join us on our journey: https://lnkd.in/eMt4CsU   #PrideMonth #PrideIs365 #EntradaHere